| Overall | Pre-Pandemic: Mar 1, 2019–May 31, 2020 | Early Pandemic: June 1, 2020–March 31, 2021 | Late Pandemic: April 1, 2021–August 31, 2021 | p-value |
---|---|---|---|---|---|
Total, N (%) | 3777 | 1655 (43.8) | 1423 (37.7) | 699 (18.5) | Â |
Age, years mean, (SD) | 49.6 (20.1) | 49.4 (20.4) | 50.2 (20.1) | 48.8 (19.6) | 0.28 |
Women, n (%) | 1859 (49.3) | 838 (50.7) | 704 (49.5) | 317 (45.4) | 0.06 |
Past medical history, n (%) | |||||
 Hypertension | 861 (22.8) | 344 (20.8) | 349 (24.5) | 168 (24.1) | 0.03 |
 Diabetes | 465 (12.3) | 185 (11.2) | 192 (13.5) | 88 (12.6) | 0.15 |
 Heart failure | 248 (6.6) | 123 (7.4) | 84 (5.9) | 41 (5.9) | 0.17 |
 Kidney disease | 154 (4.1) | 73 (4.4) | 58 (4.1) | 23 (3.3) | 0.46 |
 COPD/asthma | 115 (3.0) | 55 (3.3) | 35 (2.5) | 25 (3.6) | 0.25 |
 Liver disease | 73 (1.9) | 29 (1.8) | 35 (2.5) | 9 (1.3) | 0.14 |
 Mental health | 41 (1.1) | 19 (1.2) | 16 (1.1) | 6 (0.9) | 0.81 |
 Malignancy | 37 (1.0) | 15 (0.9) | 16 (1.1) | 6 (0.9) | 0.78 |
 Stroke | 33 (0.9) | 18 (1.1) | 12 (0.8) | 3 (0.4) | 0.29 |
HIV serostatus, n (%) | Â | Â | Â | Â | 0.001 |
 Positive | 482 (12.9) | 200 (12.2) | 168 (11.9) | 115 (16.6) |  |
 Negative | 1177 (31.5) | 496 (30.3) | 485 (34.4) | 196 (28.3) |  |
 Unknown | 2078 (55.6) | 939 (57.4) | 758 (53.7) | 381 (55.1) |  |
Length of hospital stay days, mean, (SD) | 7.0 (7.8) | 7.1 (7.7) | 6.7 (8.1) | 7.7 (7.3) | 0.02 |
Transfer to outside facility, n (%) | 31 (0.8) | 19 (1.2) | 5 (0.4) | 7 (1.0) | 0.04 |
In-hospital mortality, n (%) | 284 (7.6) | 48 (2.9) | 219 (15.4) | 17 (2.4) | < 0.001 |
distance from hospital, km mean (SD) | 43.8 (52.7) | 43.6 (53.5) | 45.8 (51.9) | 40.1 (52.5) | 0.07 |
SOFA, mean (SD) | 1.1 (1.6) | 1.0 (1.6) | 1.3 (1.7) | 1.1 (1.6) | < 0.001 |
CCI, mean (SD) | 2.0 (1.8) | 2.0 (1.8) | 2.2 (1.8) | 2.0 (1.9) | 0.02 |
Labs drawn during admission, N (%) | 1235 (33.0) | 475 (29.0) | 510 (36.1) | 250 (35.9) | < 0.001 |